Indivior Pharmaceuticals, Inc. Gross Profit 2022–2025
Indivior Pharmaceuticals, Inc. reported $994.00M of gross profit for fiscal 2025. That was 3.9% higher than fiscal 2024. Compared with fiscal 2022, the change was +32.7%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $994.00M | 80.2% | +3.9% |
| FY 2024 | $957.00M | 80.6% | +4.1% |
| FY 2023 | $919.00M | 84.1% | +22.7% |
| FY 2022 | $749.00M | 83.1% | — |
Source: Indivior Pharmaceuticals, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open INDV 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Indivior Pharmaceuticals, Inc. reported $994.00M of gross profit for fiscal 2025. That was 3.9% higher than fiscal 2024. Compared with fiscal 2022, the change was +32.7%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Indivior Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIndivior Pharmaceuticals, Inc. — frequently asked questions
What is Indivior Pharmaceuticals, Inc.'s gross profit?
Indivior Pharmaceuticals, Inc. (INDV) reported gross profit of $994.00M for fiscal year 2025, per its SEC filings.
How has Indivior Pharmaceuticals, Inc.'s gross profit changed over time?
Between fiscal 2022 and 2025, INDV's gross profit grew at roughly 9.9% per year (compound annual rate), from $749.00M to $994.00M.
Where does this data come from?
Figures are computed from Indivior Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.